PMDA drug package insert
ゾコーバ錠25mg
PMDA Prescription drug · 塩野義製薬株式会社 · package insert Aug 17, 2026
Key facts
| Brand names | ゾコーバ錠25mg, ゾコーバ錠125mg |
|---|---|
| Nonproprietary names | エンシトレルビル フマル酸 |
| Companies | 製造販売元／塩野義製薬株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗SARS-CoV-2剤 |
| Therapeutic category codes | 87625 |
| YJ codes | 6250052F2020, 6250052F1023 |
| Approval numbers | 30800AMX00156000, 30400AMX00205000 |
| Package insert edition | 第30版、用量変更 |
| Package insert date | Aug 17, 2026 |
| PMDA document key | 340018_6250052F1023_2 |
| PMDA company code | 340018 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: